Biotia is a New York-based health-tech company that fights infectious diseases by combining next-generation DNA sequencing with AI-driven software. Its metagenomic platform identifies bacteria, fungi, parasites and viruses - plus antimicrobial-resistance markers - from a single sample against a curated database of more than 16,000 microbial species. Spun out of the Jacobs Technion-Cornell Institute at Cornell Tech and operating a CLIA-certified lab in New York City, Biotia turns a single microbiome test into an actionable clinical report to help providers diagnose hard-to-detect infections and support pathogen surveillance from the hospital to outer space.
Resilienci.ai is an Austin-based digital health company using artificial intelligence, machine learning and hyperlocal data to help people and public health agencies understand and reduce infectious-disease risk. Founded by Eric Klasson and operating as a Pandemic Insights company, it builds a free consumer mobile app paired with a web-based platform for health agencies, aiming to deliver the world's first interoperable, multi-pathogen digital health solution for outbreaks and pandemics.